Croatia · Medical and donor conditions

Clinical consultation desk beside a laboratory microscope, illustrating the distinction between legal rules and clinic procedures.

Croatia: Medical and Donor Requirements for Assisted Reproduction

The short answer: surrogacy is prohibited; donor-assisted treatment is different

The promulgated text of Croatia’s Act on Medically Assisted Reproduction (NN 86/2012) distinguishes MAR for an eligible patient who will carry the pregnancy from treatment arranged for a woman to carry and deliver a child for others. Article 31 prohibits seeking or offering surrogacy, arranging or performing MAR for that purpose, and handing over the child; related transactions are void whether paid or unpaid.

Donor sperm or eggs may be used only in statutory cases; donated embryos are limited to surplus embryos from a couple’s own homologous treatment. The Act prohibits using donor sperm and donor eggs together and creating embryos for donation from donated gametes. The official Central Catalogue entry for Act NN 86/2012 was located, but its detail page was not text-extractable during this check; current consolidated status therefore remains unverified here.

What the surrogacy prohibition covers

Article 31(1) prohibits seeking or offering, by public advertisement or any other means, a service in which a woman bears a child for another person. Article 31(2) prohibits agreeing to or carrying out MAR for that purpose and transferring the child. Under Article 31(3), agreements and other legal transactions concerning that arrangement are void whether paid or unpaid.

The prohibition is not limited to commercial surrogacy. Calling an arrangement “altruistic”, reimbursing expenses, using a relative as the carrier or avoiding a formal written contract does not create an exception in Article 31. A clinic cannot make the arrangement lawful simply by labelling it ordinary IVF; the purpose of the procedure matters. In practice, do not advertise or seek a surrogate, sign a Croatian surrogacy agreement, pay an intermediary, or schedule a Croatian MAR procedure intended to result in a child being born for others and handed over. The statute does not specify every consequence of conduct abroad; territorial reach, sanctions and foreign parentage require separate case-specific advice.

Do not confuse surrogacy with donor-assisted treatment

The Act distinguishes homologous treatment using patients’ own gametes from heterologous treatment using donor gametes. Article 8 permits donor gametes when one partner’s gametes cannot be used or to prevent transmission of a serious hereditary disease. Statutory medical indications and patient eligibility still apply; donor treatment for an eligible woman who carries the pregnancy differs from treatment arranged for a surrogate to hand a child to others.

MAR may be used after infertility treatment has failed or is considered hopeless, or to prevent transmission of a serious hereditary disease through natural conception. A reproductive specialist assesses infertility; a human-genetics specialist assesses the relevant hereditary risk. A clinic’s commercial package, donor list or website does not itself establish that the statutory medical indication is met.

Embryo donation is narrow: it concerns surplus embryos from a couple’s homologous treatment, requires their express written consent, and is available only to people receiving infertility treatment in Croatia. Both members of the source couple must give written consent authenticated by a notary.

Who may access ordinary medically assisted reproduction

Article 10 covers adult, legally capable women and men in marriage or qualifying non-marital cohabitation who, given their age and general health, are capable of parental care. A woman not living in a marriage, non-marital or same-sex partnership has a narrower route only if prior infertility treatment failed or was hopeless and other forms of treatment have been found hopeless (Article 10(6)). The same age-and-general-health parental-care condition applies to this route. For applicants relying on marriage or cohabitation, the relationship must exist when gametes or embryos enter the woman’s body; marriage is proved by public documents and qualifying cohabitation by notarised declaration. This states the Act’s wording, not a conclusion on any equality or human-rights challenge.

Age 42 mainly concerns public funding: the Croatian Health Insurance Fund generally funds MAR until that birthday, but a doctor may allow later funding for particularly justified medical reasons. Treatment after 42 is not automatically unlawful. Ovarian-reserve assessment and information on success rates and risks are also required for women over 42 or with unfavourable tests. Age or relationship status alone is insufficient; medical indication, consent, counselling and an authorised clinic are also required. Article 10(6) also conditions the entitlement under Article 10(4) on a finding that other forms of treatment are hopeless; funding after 42 is therefore not automatic.

Article 10(3) also recognises a person whose legal-capacity order does not restrict declarations concerning personal status, subject to consent rules.

Medical assessment, counselling and written consent

Before treatment, patients must be told the procedure, chances of success and possible risks for the woman, man and child. The eligible patient or couple chooses the method together with the reproductive specialist. Before heterologous treatment with donor gametes, legal and psychological or psychotherapeutic counselling is mandatory. The psychological professional explains possible consequences and issues written confirmation; the clinic’s legal professional explains consent effects, family-law consequences and the child’s right to know about MAR conception and biological origins.

Each procedure requires free written consent on the prescribed form, identifying the method and origin of the gametes or embryo. The form records the patient’s signature, the responsible physician’s signature/facsimile and the institution’s stamp. Consent may be withdrawn until gametes or embryo enter the woman’s body; withdrawal stops treatment. Before introduction, the physician must check that consent has not been withdrawn. Keep the completed form and mandatory counselling confirmations.

Who may donate and how suitability is assessed

Article 17 requires a donor to be an adult, healthy and able to give valid consent under the Act; written consent is required. An egg donor may have surplus eggs from her own treatment or donate without undergoing treatment herself. Article 17 sets no universal numerical donor-age limit; suitability is assessed individually. The responsible assessing doctor also countersigns the donor’s consent.

The 2013 Rulebook requires a doctor to assess donor age, reproductive health and medical history by questionnaire/interview, consider risks to the donor and third parties, and document suitability. The clinic also reviews clinical and social history and conducts a physical examination to identify risks to the donor, recipient or future child, including transmissible disease and risks associated with egg retrieval or medication. A qualified healthcare professional must review the records and sign the assessment. Donors must understand the information, be able to ask questions, confirm their history to the best of their knowledge, and report later health changes or newly known hereditary disease.

Article 17(2) also recognises a donor subject to a legal-capacity order if it does not restrict declarations concerning personal status and the person can validly consent under the Act and family-law rules.

Donor screening: tests, genetic history and timing

The accessible 2013 Rulebook requires heterologous donors to test negative for HIV 1/2, hepatitis B and C, and syphilis. Sperm donors also need a negative urine PCR test for chlamydia. HTLV-I testing is required for specified links to high-prevalence areas. Depending on history, travel, exposure or cell characteristics, additional tests may include malaria, CMV, Trypanosoma cruzi and RhD. Required tests must be performed by a laboratory authorised by the Ministry of Health, using valid tests.

The Rulebook also requires assessment of recessive genetic variants informed by scientific knowledge and prevalence in the donor’s ethnic group, plus family-history risks such as cystic fibrosis. Results and residual risks must be explained to donor and recipient. Semen is quarantined for at least 180 days and retested; repeat testing is not required where PCR is used or validated viral inactivation is applied. Incoming donor cells remain quarantined until required tests and document checks are complete. The Ministry lists NN 70/2013 but provides no consolidated amendment/repeal history; Croatian counsel should confirm its current text and force before relying on these details.

Consent, confidentiality and the child’s right to know

Gamete donors must give free written consent; the assessing doctor countersigns it under the Rulebook. For donated embryos, both source partners must provide written consent authenticated by a notary. A donor may withdraw consent until the donated gametes or embryo enter the woman’s reproductive organs; the clinic must check for withdrawal before use. Donors have no family-law rights or duties toward the child and no right to know the woman’s or child’s identity.

The system does not guarantee lifelong anonymity. From age 18, a person conceived and born with donated sperm, eggs or an embryo may inspect the state register for conception and biological-origin information, including donor identity. Parents must tell the child by the 18th birthday that conception involved MAR. Ask how the clinic records identity, consent, tests and register entries; do not rely on “anonymous” marketing.

Payment, direct arrangements and donor-use limits

The Act prohibits payment or other benefits for gametes or embryos; necessary expenses may be reimbursed. Direct oral or written donor-recipient agreements are prohibited, and transfer-for-payment agreements are void. Donation must pass through an authorised institution; a donor may donate gametes to only one authorised institution.

Gametes from one donor may be used until three children have been born across one or more families. After the third birth, further use is prohibited and remaining gametes are destroyed; remaining donated embryos may not be donated again. Before each heterologous procedure, the clinic must check the State Register.

The Act also prohibits trading in gametes, reproductive tissues or embryos and publicly advertising, seeking or offering them. A narrow statutory exception allows an authorised gamete/tissue/embryo bank to collect gametes only with National Commission permission.

The Act also screens for prohibited family relationships: donor sperm cannot be used where donor and recipient are blood- or affinity-related or another legal marriage impediment exists. Donated eggs cannot be fertilised with sperm from a man who could not marry the donor; a donated embryo cannot be used for a woman related by blood or affinity to either gamete source.

Treatment and embryo restrictions

Controlled stimulation may produce no more than 12 eggs, and the law permits all 12 to be fertilised if that option is chosen. Before treatment, spouses or cohabiting partners must state in writing whether to fertilise up to two eggs or more. Ordinarily, no more than two embryos may be transferred; up to three is allowed only in specified cases, including women older than 38, poor ovarian reserve, repeated treatment failure, oncology patients or severe male infertility. Article 8(4) applies Article 7(2)–(8) to heterologous treatment. Because Article 7(4) uses couple-specific wording, a single eligible woman should ask the clinic in writing how it documents this choice.

Sex selection is prohibited except to avoid a serious sex-linked hereditary disease with National Commission consent. The Act also prohibits simultaneous introduction of donor sperm and donor eggs, creating embryos for donation from donated gametes, mixing sperm from multiple men or eggs from multiple women, allowing an embryo to develop outside the woman’s body beyond six days, creating embryos for research and research on embryos. The relevant provisions are Articles 27–29 and 36; embryo donation is separately addressed in Articles 8 and 18, and kinship restrictions in Article 25.

Unused embryos are generally stored at the Health Insurance Fund’s expense for up to five years. They may then be donated only with the source couple’s consent, or storage may be extended another five years at the couple’s expense. Article 7(9) separately requires, before a new fresh IVF cycle, all frozen embryos to be used first and then frozen eggs. Article 8(4) expressly applies only Article 7(2)–(8) to heterologous treatment; do not assume Article 7(9)’s sequencing rule applies to a heterologous cycle without confirmation from Croatian counsel.

Clinic authorisation, committee approval and records

Only a healthcare institution authorised by the Minister of Health may perform MAR; its authorisation identifies covered methods. These can include IUI, IVF, ICSI, gamete/tissue/embryo freezing and thawing, fallopian-tube transfer and preimplantation genetic diagnosis. A website, foreign accreditation or commercial partnership does not prove current Croatian authorisation.

Each heterologous procedure needs approval from the institution’s five-member MAR committee on a human-reproduction specialist’s recommendation; at least one member must be a human-reproduction specialist, one a biology graduate and one a legal professional. The clinic must check the State Register and keep patient, donor, procedure, counselling, consent and treatment records. Request the exact method authorisation, committee approval, donor-screening protocol, register-check confirmation and consent/counselling records before signing or paying. The accessible Rulebook states that donor data are retained permanently and traceability medical documentation for at least 30 years; counsel should confirm these periods under the current rule.

Decision matrix: law, clinical assessment and clinic policy

Use this matrix to identify the next question for the clinic or lawyer. It is an initial screening tool, not a substitute for checking the exact method and current law.

Situation Binding rule / condition Next step
Surrogate in Croatia Seeking, offering or carrying out MAR for another person is prohibited; the agreement is void, paid or unpaid. Stop the arrangement and obtain Croatian legal advice.
Intended patient will carry the pregnancy using donor gametes Potentially available only if statutory eligibility, medical indication, donor, consent and clinic rules are met. Ask for written eligibility confirmation and authorisation for the exact method.
Donor screening The accessible Rulebook specifies donor assessment and tests; additional tests may depend on risk. Current status must be confirmed. Request the legal basis, full test panel, laboratory protocol and written results.
Payment or private donor deal No payment or other benefit; necessary expenses only. Direct agreements are prohibited; donor-use limits and register checks apply. Use an authorised institution, document expenses and confirm the register check.

Practical pre-treatment checklist and limits of this guide

If a surrogate would carry and hand over a child in Croatia, stop before payments, agreements, advertising, matching or embryo transfer. Get written Croatian legal advice on the facts, including cross-border elements. Calling the plan altruistic or donor IVF does not avoid Article 31.

If the patient will carry the pregnancy, ask the clinic to confirm eligibility, medical indication, method-specific authorisation and committee approval. Request donor-screening and genetic-risk records, the laboratory protocol, the State Register check and written results. Keep the prescribed consent form with physician signature/facsimile and institution stamp. For donated embryos, verify notarised consent from both source partners; a single woman should request written clarification of how the egg-fertilisation choice is recorded.

Before relying on timing, tests, reimbursement or embryo numbers, ask Croatian counsel to verify the applicable text and clinic-specific requirements. This guide does not decide cross-border enforcement, foreign parentage, nationality or travel documents. The artwork is illustrative, not a verified photograph of a Croatian clinic.

Legal sources

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards